These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 25601395

  • 1. Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses.
    Batista LA, Bastos JR, Moreira FA.
    J Psychopharmacol; 2015 Mar; 29(3):335-43. PubMed ID: 25601395
    [Abstract] [Full Text] [Related]

  • 2. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
    Viana TG, Hott SC, Resstel LB, Aguiar DC, Moreira FA.
    Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
    [Abstract] [Full Text] [Related]

  • 3. Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey.
    Gobira PH, Almeida-Santos AF, Guimaraes FS, Moreira FA, Aguiar DC.
    Eur Neuropsychopharmacol; 2016 Jan; 26(1):15-22. PubMed ID: 26628106
    [Abstract] [Full Text] [Related]

  • 4. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test.
    Lisboa SF, Resstel LB, Aguiar DC, Guimarães FS.
    Eur J Pharmacol; 2008 Sep 28; 593(1-3):73-8. PubMed ID: 18691568
    [Abstract] [Full Text] [Related]

  • 5. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
    Lisboa SF, Guimarães FS.
    Neuropharmacology; 2012 Jun 28; 62(8):2455-62. PubMed ID: 22394688
    [Abstract] [Full Text] [Related]

  • 6. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray.
    Almeida-Santos AF, Gobira PH, Rosa LC, Guimaraes FS, Moreira FA, Aguiar DC.
    Behav Brain Res; 2013 Sep 01; 252():10-7. PubMed ID: 23714073
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation.
    Batista LA, Moreira FA.
    Neurosci Lett; 2019 Jun 11; 703():5-10. PubMed ID: 30858018
    [Abstract] [Full Text] [Related]

  • 8. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
    Moreira FA, Aguiar DC, Guimarães FS.
    Neuropharmacology; 2007 Mar 11; 52(3):958-65. PubMed ID: 17156799
    [Abstract] [Full Text] [Related]

  • 9. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
    Lisboa SF, Magesto AC, Aguiar JC, Resstel LB, Guimarães FS.
    Neuropharmacology; 2013 Dec 11; 75():86-94. PubMed ID: 23899460
    [Abstract] [Full Text] [Related]

  • 10. CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus.
    Dos Anjos-Garcia T, Ullah F, Falconi-Sobrinho LL, Coimbra NC.
    Neuropharmacology; 2017 Feb 11; 113(Pt A):156-166. PubMed ID: 27062913
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
    Hartmann A, Fassini A, Scopinho A, Correa FM, Guimarães FS, Lisboa SF, Resstel LB.
    J Psychopharmacol; 2019 May 11; 33(5):606-614. PubMed ID: 30789299
    [Abstract] [Full Text] [Related]

  • 13. Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks.
    Viana TG, Bastos JR, Costa RB, Hott SC, Mansur FS, Coimbra CC, Resstel LB, Aguiar DC, Moreira FA.
    Neuropharmacology; 2019 Apr 11; 148():284-290. PubMed ID: 30677422
    [Abstract] [Full Text] [Related]

  • 14. Panicolytic-like effect induced by the stimulation of GABAA and GABAB receptors in the dorsal periaqueductal grey of rats.
    Bueno CH, Zangrossi H, Nogueira RL, Soares VP, Viana MB.
    Eur J Pharmacol; 2005 Jun 15; 516(3):239-46. PubMed ID: 15975569
    [Abstract] [Full Text] [Related]

  • 15. Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats.
    Almeida-Santos AF, Moreira FA, Guimarães FS, Aguiar DC.
    Pharmacol Biochem Behav; 2013 Apr 15; 105():166-72. PubMed ID: 23474373
    [Abstract] [Full Text] [Related]

  • 16. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA, Kaiser N, Monory K, Lutz B.
    Neuropharmacology; 2008 Jan 15; 54(1):141-50. PubMed ID: 17709120
    [Abstract] [Full Text] [Related]

  • 17. The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.
    Batista PA, Fogaça MV, Guimarães FS.
    Behav Brain Res; 2015 Oct 15; 293():182-8. PubMed ID: 26187694
    [Abstract] [Full Text] [Related]

  • 18. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S, Nomikos GG, Panagis G.
    Psychopharmacology (Berl); 2006 Oct 15; 188(3):293-305. PubMed ID: 16953388
    [Abstract] [Full Text] [Related]

  • 19. Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats.
    Resstel LB, Lisboa SF, Aguiar DC, Corrêa FM, Guimarães FS.
    Psychopharmacology (Berl); 2008 Jun 15; 198(3):405-11. PubMed ID: 18446325
    [Abstract] [Full Text] [Related]

  • 20. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
    Cross-Mellor SK, Ossenkopp KP, Piomelli D, Parker LA.
    Psychopharmacology (Berl); 2007 Feb 15; 190(2):135-43. PubMed ID: 17111174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.